UK markets closed

Valeo Pharma Inc. (VPH.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
0.09500.0000 (0.00%)
At close: 04:00PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 9.37M
Enterprise value 65.53M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.15
Price/book (mrq)N/A
Enterprise value/revenue 1.42
Enterprise value/EBITDA -6.71

Trading information

Stock price history

Beta (5Y monthly) 2.59
52-week change 3-77.91%
S&P500 52-week change 326.27%
52-week high 30.4400
52-week low 30.0600
50-day moving average 30.1476
200-day moving average 30.2036

Share statistics

Avg vol (3-month) 357.7k
Avg vol (10-day) 331.94k
Shares outstanding 598.66M
Implied shares outstanding 6109.04M
Float 845.29M
% held by insiders 147.12%
% held by institutions 17.24%
Shares short (30 Apr 2024) 42.21k
Short ratio (30 Apr 2024) 40.02
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.00%
Shares short (prior month 28 Mar 2024) 413.55k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Oct 2023
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin -52.37%
Operating margin (ttm)-35.92%

Management effectiveness

Return on assets (ttm)-23.07%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)54.29M
Revenue per share (ttm)0.62
Quarterly revenue growth (yoy)2.90%
Gross profit (ttm)N/A
EBITDA -14.09M
Net income avi to common (ttm)-28.43M
Diluted EPS (ttm)-0.3200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.59M
Total cash per share (mrq)0.1
Total debt (mrq)66.36M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.49
Book value per share (mrq)-0.48

Cash flow statement

Operating cash flow (ttm)-2.97M
Levered free cash flow (ttm)-5.8M